Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress

Bibliographic Details
Main Authors:	Marwan N. Sabbagh, Kaj Blennow
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2019-12-01
Series:	Neurology and Therapy
Online Access:	https://doi.org/10.1007/s40120-019-00171-6

Similar Items

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
by: Seema Patel, et al.
Published: (2011-01-01)

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer’s disease
by: Carina Wattmo, et al.
Published: (2020-01-01)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
by: Niklas Mattsson, et al.
Published: (2010-01-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
by: Henrik Zetterberg, et al.
Published: (2021-02-01)

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
by: Nicholas J. Ashton, et al.
Published: (2019-12-01)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
by: Nicholas J. Ashton, et al.
Published: (2021-06-01)

Comparing progression biomarkers in clinical trials of early Alzheimer’s disease
by: Nicholas C. Cullen, et al.
Published: (2020-09-01)

The past and the future of Alzheimer’s disease CSF biomarkers – a journey towards validated biochemical tests covering the whole spectra of molecular events
by: Kaj eBlennow
Published: (2015-09-01)

Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?
by: Lucilla Parnetti, et al.
Published: (2010-01-01)

Biomarkers for Microglial Activation in Alzheimer's Disease
by: Ronald Lautner, et al.
Published: (2011-01-01)

Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
by: Laia Montoliu-Gaya, et al.
Published: (2021-08-01)

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
by: Christopher Clark, et al.
Published: (2021-03-01)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Ulf Andreasson, et al.
Published: (2016-01-01)

Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
by: Peder Buchhave, et al.
Published: (2009-01-01)

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
by: Cummings Jeffrey, et al.
Published: (2011-02-01)

Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease
by: Tania Marcourakis, et al.

Study on Analysis of Peripheral Biomarkers for Alzheimer’s Disease Diagnosis
by: Palaniswamy Rani, et al.
Published: (2017-07-01)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
by: Niels Andreasen, et al.
Published: (2010-01-01)

Molecular biomarkers of Alzheimer's disease: progress and prospects
by: Tammaryn Lashley, et al.
Published: (2018-05-01)

Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease
by: Xiaoyu Dong, et al.
Published: (2019-12-01)

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.
by: Mikko Hölttä, et al.
Published: (2013-01-01)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
by: Mona Mehta, et al.
Published: (2012-01-01)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-07-01)

Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
by: Oskar Hansson, et al.
Published: (2020-01-01)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease
by: Annika Öhrfelt, et al.
Published: (2011-01-01)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
by: Laila Abdullah, et al.
Published: (2020-03-01)

A systematic review of biomarkers for disease progression in Alzheimer's disease.
by: David J M McGhee, et al.
Published: (2014-01-01)

Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.
by: Alexander Schmidt-Richberg, et al.
Published: (2016-01-01)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
by: Flora H. Duits, et al.
Published: (2018-01-01)

Advances with Long Non-Coding RNAs in Alzheimer’s Disease as Peripheral Biomarker
by: Maria Garofalo, et al.
Published: (2021-07-01)

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
by: Camryn Berk, et al.
Published: (2012-01-01)

Novel Therapeutics in Alzheimer's Disease
by: Marwan Sabbagh, et al.
Published: (2012-01-01)

Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.
by: Jere E Meredith, et al.
Published: (2013-01-01)

Update on Alzheimer’s Disease
by: Kurt A. Jellinger
Published: (2015-08-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
by: Hákon Valur Dansson, et al.
Published: (2021-09-01)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
by: The Staff
Published: (2014-01-01)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease.
Published: (2014-01-01)

CSF sTREM2 in delirium—relation to Alzheimer’s disease CSF biomarkers Aβ42, t-tau and p-tau
by: Kristi Henjum, et al.
Published: (2018-11-01)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
by: Sebastian Palmqvist, et al.
Published: (2019-12-01)

Amyloid precursor protein in peripheral granulocytes as a potential biomarker for Alzheimers disease
by: Xiaonan Wang, et al.
Published: (2016-03-01)